The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...

The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...

The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...

The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...

In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...

A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it’s usefulness.

A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

According to a letter released by the FDA, the advertisement makes false or misleading claims about the drug's efficacy in treating migraine pain. The agency added that the ad exaggerates the speed ...

AbbVie's TV spots say that all patients who take the drug, called Ubrelvy, can expect their migraine pain to be eliminated ...